0.7607
price up icon3.41%   0.0251
after-market Dopo l'orario di chiusura: .74 -0.0207 -2.72%
loading
Precedente Chiudi:
$0.7356
Aprire:
$0.767
Volume 24 ore:
84,795
Relative Volume:
0.03
Capitalizzazione di mercato:
$12.34M
Reddito:
$2.05M
Utile/perdita netta:
$-23.15M
Rapporto P/E:
-0.1147
EPS:
-6.6319
Flusso di cassa netto:
$-16.93M
1 W Prestazione:
+3.92%
1M Prestazione:
+6.78%
6M Prestazione:
-74.73%
1 anno Prestazione:
-67.21%
Intervallo 1D:
Value
$0.7605
$0.767
Intervallo di 1 settimana:
Value
$0.7159
$0.767
Portata 52W:
Value
$0.6358
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Nome
iBio Inc
Name
Telefono
302-355-0650
Name
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
IBIO's Discussions on Twitter

Confronta IBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IBIO
iBio Inc
0.7607 11.93M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-28 Iniziato Chardan Capital Markets Buy
2021-11-29 Iniziato JMP Securities Mkt Outperform
2021-01-22 Iniziato Cantor Fitzgerald Overweight
2020-06-26 Iniziato Alliance Global Partners Buy

iBio Inc Borsa (IBIO) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about iBio Inc. stockHigh-profit trading signals - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives iBio Inc. stock priceSkyrocketing profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

iBio Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is iBio Inc. a good long term investmentExplosive earning power - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

how ibio stock performs during market volatilityFree Short-Term Stock Picks - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

what makes ibio inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying iBio Inc. stock nowFree Access to Investment Community - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why iBio Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes iBio Inc. stock price move sharplyChart Based Entries - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

How iBio Inc. stock performs during market volatilityFree Access to Investors Club - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

iBio (NYSEMKT:IBIO) Stock Price Down 0% – What’s Next? - Defense World

Jul 11, 2025
pulisher
Jun 24, 2025

iBio stock soars after amylin receptor antibody shows promising results - Investing.com

Jun 24, 2025
pulisher
Jun 24, 2025

iBio Advances Obesity Care with Antibody Therapies - TipRanks

Jun 24, 2025
pulisher
Jun 24, 2025

iBio (IBIO) Reports Promising Preclinical Results in Obesity Stu - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

US Stocks Likely To Open Higher After Trump Announces Iran-Israel Ceasefire: FedEx, TD Synnex In Focus Ahead Of EarningsBlackBerry (NYSE:BB), Carnival (NYSE:CCL) - Benzinga

Jun 24, 2025
pulisher
Jun 23, 2025

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agon - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

iBio's Next-Gen Obesity Therapies: A Strategic Pipeline with Transformative Potential - AInvest

Jun 23, 2025
pulisher
Jun 19, 2025

iBio Extends Promissory Note Maturity to 2026 - TipRanks

Jun 19, 2025
pulisher
Jun 17, 2025

Ibio nominates IBIO-610 as obesity development candidate - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

iBio (IBIO) Begins Preclinical Study of New Antibody Candidate | - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment | IBIO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

iBio initiates non-human primate study of IBIO-610 - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Breakthrough Obesity Drug Shows 77% Fat Reduction When Combined With GLP-1 Treatments - Stock Titan

Jun 16, 2025
pulisher
Jun 13, 2025

iBio (IBIO) Plans to Offer 11.25 Million Shares of Common Stock - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Sector Update: Health Care - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

IBio Files Prospectus for Resale of About 11.3 Million Shares - marketscreener.com

Jun 13, 2025
pulisher
Jun 10, 2025

Plant-Based Vaccines Market Future Business Opportunities 2025-2032 | Medicago, Inc., IBIO, Icon Genetics GmbH - newstrail.com

Jun 10, 2025
pulisher
May 29, 2025

iBio: University of Limerick programme to ‘shape the next generation’ of pharmaceutical manufacturing experts - University of Limerick

May 29, 2025
pulisher
May 23, 2025

Merck & Co., Inc. (MRK): A Bull Case Theory - MSN

May 23, 2025
pulisher
May 14, 2025

Plant-Based Vaccines Market Detailed In New Research Report - openPR.com

May 14, 2025
pulisher
May 11, 2025

Insiders Who Purchased US$655.0k Of iBio Stock May Not Have Expected 23% Tumble - simplywall.st

May 11, 2025
pulisher
May 11, 2025

Insider Buyers At iBio Likely Disappointed With 23% Slide - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

Chardan Capital Has Pessimistic View of iBio FY2025 Earnings - Defense World

May 11, 2025

iBio Inc Azioni (IBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):